Literature DB >> 16115798

Increased left atrial volume index is an independent predictor of raised serum natriuretic peptide in patients with suspected heart failure but normal left ventricular ejection fraction: Implication for diagnosis of diastolic heart failure.

Tiong K Lim1, Houman Ashrafian, Girish Dwivedi, Paul O Collinson, Roxy Senior.   

Abstract

BACKGROUND: Left atrial volume index (LAVI) is increasingly recognised as a relatively load-independent marker of left ventricular (LV) filling pressures. We assessed the capacity of LAVI to predict LV diastolic dysfunction in comparison with N-terminal pro B-type natriuretic peptide (NTproBNP) in patients with suspected heart failure and a normal ejection fraction (EF).
METHODS: 137 patients with suspected heart failure (HF), referred from the community for echocardiography, prospectively underwent Doppler echocardiography, LAVI and NTproBNP estimation. Raised LAVI and reduced LV systolic function were defined as >26 ml/m2 and LV EF <50% respectively.
RESULTS: Of 137 patients, 21 were excluded (2 with significant mitral valve disease and 19 with atrial fibrillation). Of the remaining 116 subjects, 92 showed normal LV systolic function. The univariate predictors of serum log NTproBNP were age (p < 0.001), LA dimension (p = 0.001), LAVI (p < 0.001), A wave (p = 0.001), E:A (p = 0.07) and septal wall thickness (p = 0.004). However on multivariate analysis, LAVI was found to be the most consistent and significant predictor of NTproBNP. The area under the curve of the receiver operating characteristic (ROC) curve for NTproBNP in detecting patients with LVEF > or = 50% and LAVI >26 ml/m2 was 0.81 (p < 0.0001) and for patients with LAVI > 26 ml/m2 with and without LVEF > or = 50% was 0.82 (p < 0.0001).
CONCLUSION: This data confirms that LAVI on resting echocardiography, specifically in patients with suspected HF and normal LV systolic function is a powerful independent predictor of LV diastolic dysfunction as predicted by serum NTproBNP. In a population with a high suspicion of diastolic heart failure, LAVI may significantly contribute to diagnostic precision.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16115798     DOI: 10.1016/j.ejheart.2005.05.008

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  23 in total

1.  Left atrial volume change throughout the cardiac cycle in children with congenital heart disease associated with increased pulmonary blood flow: evaluation using a novel left atrium-tracking method.

Authors:  Miho Sakata; Yasunobu Hayabuchi; Miki Inoue; Tatsuya Onishi; Shoji Kagami
Journal:  Pediatr Cardiol       Date:  2012-06-04       Impact factor: 1.655

2.  Assessment of left atrial function in diabetes mellitus by left atrial volume tracking method.

Authors:  Gui Huang; Li Zhang; Mingxing Xie; Manli Fu; Junhong Huang; Qing Lv
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-12-22

3.  Clinical implications of left atrial enlargement: a review.

Authors:  Dharmendrakumar A Patel; Carl J Lavie; Richard V Milani; Sangeeta Shah; Yvonne Gilliland
Journal:  Ochsner J       Date:  2009

4.  Diastolic dysfunction without abnormalities in left atrial and left ventricular geometry does not affect quality of life in elderly women.

Authors:  Alfried Germing; Michael Gotzmann; Tamara Schikowski; Andrea Vierkötter; Ulrich Ranft; Andreas Mügge
Journal:  Exp Clin Cardiol       Date:  2011

5.  Abnormalities in cardiac structure and function in adults with sickle cell disease are not associated with pulmonary hypertension.

Authors:  Jessica E Knight-Perry; Lisa de Las Fuentes; Alan D Waggoner; Raymond G Hoffmann; Morey A Blinder; Victor G Dávila-Román; Joshua J Field
Journal:  J Am Soc Echocardiogr       Date:  2011-08-27       Impact factor: 5.251

Review 6.  Natriuretic peptides in heart failure: where we are, where we are going.

Authors:  Alberto Palazzuoli; Giovanni Antonelli; Ilaria Quatrini; Ranuccio Nuti
Journal:  Intern Emerg Med       Date:  2010-09-18       Impact factor: 3.397

Review 7.  Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure.

Authors:  A Palazzuoli; M Gallotta; I Quatrini; R Nuti
Journal:  Vasc Health Risk Manag       Date:  2010-06-01

8.  Prognostic impact of atrial rhythm and dimension in patients with structural heart disease undergoing cardiac sympathetic denervation for ventricular arrhythmias.

Authors:  Veronica Dusi; Julie M Sorg; Jeffrey Gornbein; Jean Gima; Jane Yanagawa; Jay M Lee; Natalia Vecerek; Marmar Vaseghi; Jason S Bradfield; Gaetano M De Ferrari; Kalyanam Shivkumar; Olujimi A Ajijola
Journal:  Heart Rhythm       Date:  2019-12-16       Impact factor: 6.343

9.  Echocardiographic Assessment of Right Atrial Pressure in a Pediatric and Young Adult Population.

Authors:  Bhawna Arya; Diane Kerstein; Cheng-Shiun Leu; Denise Hayes; Warren A Zuckerman; Usha Krishnan; Wyman W Lai
Journal:  Pediatr Cardiol       Date:  2015-12-14       Impact factor: 1.655

Review 10.  The role of natriuretic peptides for the diagnosis of left ventricular dysfunction.

Authors:  Alberto Palazzuoli; Matteo Beltrami; Gaetano Ruocco; Marco Pellegrini; Ranuccio Nuti
Journal:  ScientificWorldJournal       Date:  2013-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.